close
close

According to The Telegraph, Eli Lilly’s Alzheimer’s drug will be banned from the British health service NHS


According to The Telegraph, Eli Lilly’s Alzheimer’s drug will be banned from the British health service NHS

(Reuters) – Britain’s National Health Service (NHS) is likely to block the use of a drug developed by Eli Lilly to treat early-stage Alzheimer’s disease, the Telegraph reported on Friday. The drug Donanemab has been rejected by the National Institute for Health and Care Excellence (NICE), which decides which drugs are available on the NHS, […]